This article discusses a new approach to the treatment of one of the most serious diseases of the retina-age-related degeneration of the macula, which produces persistent reduction of visual acuity. For effective and minimally traumatic treatment, it is proposed to use the combined action of medications with photodynamic therapy and thermal therapy based on the IR photosensitizer Indocyanine Green. The possibility is considered of increasing the treatment efficiency by enhancing the quantum yield of singlet oxygen and increasing the optical density of the photosensitizer by encapsulating it inside polymeric nanocarriers. (C) 2015 Optical Society of America.
展开▼